In the January 2016 edition of Financier Worldwide, Dr. Gregory K. Bell discusses how mergers and acquisitions can create shareholder value in the life sciences sector. The roundtable discussion is moderated by James C. Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO). To read the article, click the link below.
Vertical mergers and consumer Impact: new articles from Michael Salinger and Martino De Stefano
CRA congratulates Senior Consultant and Boston University Professor Michael Salinger and CRA Vice President Martino De Stefano for recently publishing two...